Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-18

Clinical Trial Update: International Trial of Efficacy of Cytoflavin in Head Trauma [Phase 3]

View source ↗

Summary

Phase 3 international trial evaluating Cytoflavin for traumatic brain injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cytoflavin

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Head Trauma,Closed | Phase 3 | Status: COMPLETED